FF.MI 6.82 (-2.57%)
IT0005215329Drug ManufacturersDrug Manufacturers - Specialty & Generic

Fine Foods & Pharmaceuticals NTM (FF.MI) Competitor Comparison

We are evaluating the key criteria listed to compare Fine Foods & Pharmaceuticals NTM (FF.MI) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 5 years - FF.MI ranking 0 / 54

These are the competitors of Fine Foods & Pharmaceuticals NTM in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 5 years
1. Green Thumb Industries R9U2.F
119.33
2. Avadel Pharmaceuticals AVDL
40.39
3. ProPhase Labs PRPH
32.25
4. Phibro Animal Health PAHC
22.07
5. Catalent CTLT
20.24
6. Pacira BioSciences PCRX
12.98
7. Alvotech ALVO
10.71
8. Linc LNC
9.01
9. Neoleukin Therapeutics NLTX
8.58
10. Kamada KMDA
8.57
11. Alimera Sciences ALIM
7.82
12. Vifor Pharma G2AB.F
7.23
13. Curaleaf Holdings CURLF
6.97
14. Organogenesis Holdings ORGO
6.91
15. PetIQ PETQ
6.43
16. Zoetis ZTS
5.78
17. Perrigo PRGO
5.17
18. Bausch Health Companies BHC
4.97
19. Kolinpharma KIP.MI
4.88
20. Elanco Animal Health ELAN
4.57
21. Theratechnologies THTX
4.01
22. Ayr Wellness 3KJB.F
3.71
23. Amphastar Pharmaceuticals AMPH
3.65
24. Taro Pharmaceutical Industries TARO
3.55
25. Cumberland Pharmaceuticals CPIX
3.47
26. Ironwood Pharmaceuticals IRWD
3.36
27. Journey Medical DERM
2.88
28. Cronos Group CRON
2.82
29. Supernus Pharmaceuticals SUPN
2.74
30. Emergent BioSolutions EBS
2.62
31. Procaps Group PROC
2.59
32. Collegium Pharmaceutical COLL
2.55
33. Solid Biosciences SLDB
2.55
34. Zynerba Pharmaceuticals ZYNE
2.47
35. Embecta EMBC
2.43
36. Jupiter Wellness JUPW
2.39
37. ANI Pharmaceuticals ANIP
2.3
38. Societal CDMO SCTL
2.21
39. Eagle Pharmaceuticals EGRX
2.19
40. SCYNEXIS SCYX
2.15
41. Relmada Therapeutics RLMD
2.06
42. Clever Leaves Holdings CLVR
1.87
43. Alpha Teknova TKNO
1.83
44. OptiNose OPTN
1.83
45. Tilray Brands TLRY
1.8
46. Ascend Wellness Holdings AAWH
1.77
47. Biofrontera BFRI
1.74
48. Teva Pharmaceutical Industries TEVA
1.63
49. Flora Growth FLGC
1.63
50. Universe Pharmaceuticals UPC
1.61
51. Evolus EOLS
1.13
52. Regencell Bioscience Holdings RGC
0.87
53. Amneal Pharmaceuticals AMRX
0.83
54. Harrow Health HROW
0.42

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.